- Home
- HYLN vs AVIR Comparison
HYLN vs AVIR Comparison
Compare HYLN & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HYLN
- AVIR
- Stock Information
- Founded
- HYLN 2018
- AVIR 2012
- Country
- HYLN United States
- AVIR United States
- Employees
- HYLN N/A
- AVIR N/A
- Industry
- HYLN Construction/Ag Equipment/Trucks
- AVIR Medicinal Chemicals and Botanical Products
- Sector
- HYLN Consumer Discretionary
- AVIR Health Care
- Exchange
- HYLN Nasdaq
- AVIR Nasdaq
- Market Cap
- HYLN 279.7M
- AVIR 273.7M
- IPO Year
- HYLN N/A
- AVIR 2020
- Fundamental
- Price
- HYLN $1.43
- AVIR $3.01
- Analyst Decision
- HYLN Hold
- AVIR Hold
- Analyst Count
- HYLN 1
- AVIR 1
- Target Price
- HYLN $2.00
- AVIR $6.88
- AVG Volume (30 Days)
- HYLN 1.0M
- AVIR 263.3K
- Earning Date
- HYLN 04-29-2025
- AVIR 03-06-2025
- Dividend Yield
- HYLN N/A
- AVIR N/A
- EPS Growth
- HYLN N/A
- AVIR N/A
- EPS
- HYLN N/A
- AVIR N/A
- Revenue
- HYLN $1,509,000.00
- AVIR N/A
- Revenue This Year
- HYLN $1,360.04
- AVIR N/A
- Revenue Next Year
- HYLN $64.35
- AVIR N/A
- P/E Ratio
- HYLN N/A
- AVIR N/A
- Revenue Growth
- HYLN 124.55
- AVIR N/A
- 52 Week Low
- HYLN $1.21
- AVIR $2.75
- 52 Week High
- HYLN $4.10
- AVIR $4.15
- Technical
- Relative Strength Index (RSI)
- HYLN 34.46
- AVIR 41.74
- Support Level
- HYLN $1.33
- AVIR $2.90
- Resistance Level
- HYLN $1.68
- AVIR $3.29
- Average True Range (ATR)
- HYLN 0.11
- AVIR 0.12
- MACD
- HYLN 0.01
- AVIR -0.01
- Stochastic Oscillator
- HYLN 24.29
- AVIR 17.95
About HYLN Hyliion Holdings Corp.
Hyliion Holdings Corp provides solutions that enable clean, flexible, and affordable electricity production. The Company focuses on delivering distributed power generators that can operate on various fuel sources to future-proof against an ever-changing energy economy. It is initially targeting the commercial and waste management industries with a locally deployable generator that can offer prime power as well as energy arbitrage opportunities. In addition to stationary power solutions, it focuses on mobile applications, including vehicles and marine technologies.
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).